Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-24-016954
Filing Date
2024-04-29
Accepted
2024-04-29 16:05:24
Documents
15
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 200170
2 ex31-1.htm EX-31.1 7514
3 ex31-2.htm EX-31.2 7557
  Complete submission text file 0001493152-24-016954.txt   464044

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aztr-20231231.xsd EX-101.SCH 3018
5 XBRL LABEL FILE aztr-20231231_lab.xml EX-101.LAB 36884
6 XBRL PRESENTATION FILE aztr-20231231_pre.xml EX-101.PRE 24148
18 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 7540
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41705 | Film No.: 24890590
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)